Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEET

v3.21.2
CONDENSED BALANCE SHEET
Sep. 30, 2021
USD ($)
Current Assets:  
Cash $ 141,499
Total Current Assets 141,499
Deferred offering costs 861,261
Total Assets 1,002,760
Current Liabilities:  
Accrued Expenses 687,976
Promissory Note - Sponsor 300,000
Total Current Liabilities 987,976
Commitments
Shareholder's Equity  
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none outstanding 0
Additional paid in capital 24,425
Accumulated deficit (10,216)
Total Shareholder's Equity 14,784
Total Liabilities and Shareholder's Equity 1,002,760
Class A Ordinary Shares [Member]  
Shareholder's Equity  
Ordinary shares - $0.0001 par value 0
Class B Ordinary Share [Member]  
Shareholder's Equity  
Ordinary shares - $0.0001 par value $ 575 [1],[2]
[1] Includes an aggregate of up to 750,000 Class B ordinary shares that were subject to forfeiture if the over-allotment was not exercised in full or in part by the underwriter. On October 13, 2021, the underwriter exercised the full over-allotment option.
[2] Our initial shareholders initially held 7,187,000 Class B ordinary shares, up to 937,500 of which were subject to forfeiture by our sponsor depending on the extent to which the underwriters’ over-allotment option is exercised. On August 20, 2021, the sponsor surrendered for no consideration 1,287,000 Class B ordinary shares of the Company. On September 9, 2021, the sponsor surrendered an additional 150,000 Class B ordinary shares for no consideration. All share and per-share amounts have been retroactively restated to reflect the share capitalization and return of shares.